Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ProTransit NanoTherapy

ProTransit NanoTherapy
2013 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Grant LATEST DEAL TYPE (Announced)
4 INVESTORS
Description

Provider of a proprietary nanoparticle delivery system intended to treat conditions caused or related to free radical formation. The company's initial system is for skincare, where the application helps to reduce cellular and DNA damage caused by UV exposure, as well as helps to treat acute spinal cord injury, enabling physicians to treat their patients in an enhanced way.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Drug Discovery
Other Healthcare Services
Primary Office
  • 16514 L Street
  • Omaha, NE 68135
  • United States

+1 (608) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ProTransit NanoTherapy’s full profile, request a free trial.

ProTransit NanoTherapy Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 13-Aug-2018 00000 Announced Pre-Clinical Trials
2. Grant 08-Mar-2017 00.00 00000 Completed Pre-Clinical Trials
1. Early Stage VC (Series A) 21-Nov-2014 $250K $250K Completed Pre-Clinical Trials
To view this company’s complete deal history including valuation and funding, request access »

ProTransit NanoTherapy Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
United States Department of Defense Government 000 0000 000000 0
Invest Nebraska Venture Capital Minority 000 0000 000000 0
Notox Technologies Corporate Venture Capital Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0

ProTransit NanoTherapy Executive Team (2)

Name Title Board
Seat
Contact
Info
Gary Madsen Ph.D Co-Founder, President & Chief Executive Officer
Vinod Labhasetwar Ph.D Co-Founder